nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoxitin—Azotaemia—Vincristine—muscle cancer	0.0312	0.0312	CcSEcCtD
Cefoxitin—Induration—Etoposide—muscle cancer	0.0301	0.0301	CcSEcCtD
Cefoxitin—Bone marrow depression—Vincristine—muscle cancer	0.0246	0.0246	CcSEcCtD
Cefoxitin—Nephropathy toxic—Etoposide—muscle cancer	0.0234	0.0234	CcSEcCtD
Cefoxitin—Aplastic anaemia—Dactinomycin—muscle cancer	0.0175	0.0175	CcSEcCtD
Cefoxitin—Prothrombin level increased—Doxorubicin—muscle cancer	0.017	0.017	CcSEcCtD
Cefoxitin—Phlebitis—Dactinomycin—muscle cancer	0.0157	0.0157	CcSEcCtD
Cefoxitin—Azotaemia—Methotrexate—muscle cancer	0.0151	0.0151	CcSEcCtD
Cefoxitin—Vaginal moniliasis—Doxorubicin—muscle cancer	0.0138	0.0138	CcSEcCtD
Cefoxitin—Vulvovaginal candidiasis—Doxorubicin—muscle cancer	0.0133	0.0133	CcSEcCtD
Cefoxitin—Candida infection—Etoposide—muscle cancer	0.0128	0.0128	CcSEcCtD
Cefoxitin—Vulvovaginal mycotic infection—Doxorubicin—muscle cancer	0.0128	0.0128	CcSEcCtD
Cefoxitin—Local reaction—Doxorubicin—muscle cancer	0.0126	0.0126	CcSEcCtD
Cefoxitin—Rash maculo-papular—Etoposide—muscle cancer	0.0122	0.0122	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.0121	0.0121	CcSEcCtD
Cefoxitin—Bone marrow depression—Methotrexate—muscle cancer	0.0119	0.0119	CcSEcCtD
Cefoxitin—Phlebitis—Etoposide—muscle cancer	0.0113	0.0113	CcSEcCtD
Cefoxitin—Pancytopenia—Dactinomycin—muscle cancer	0.0111	0.0111	CcSEcCtD
Cefoxitin—Neutropenia—Dactinomycin—muscle cancer	0.0109	0.0109	CcSEcCtD
Cefoxitin—Bone marrow depression—Doxorubicin—muscle cancer	0.0103	0.0103	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.0103	0.0103	CcSEcCtD
Cefoxitin—Pancytopenia—Vincristine—muscle cancer	0.00989	0.00989	CcSEcCtD
Cefoxitin—Neutropenia—Vincristine—muscle cancer	0.00974	0.00974	CcSEcCtD
Cefoxitin—Agranulocytosis—Dactinomycin—muscle cancer	0.0097	0.0097	CcSEcCtD
Cefoxitin—Erythema multiforme—Dactinomycin—muscle cancer	0.00883	0.00883	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00879	0.00879	CcSEcCtD
Cefoxitin—Flushing—Dactinomycin—muscle cancer	0.00866	0.00866	CcSEcCtD
Cefoxitin—Urinary tract disorder—Vincristine—muscle cancer	0.00824	0.00824	CcSEcCtD
Cefoxitin—Urethral disorder—Vincristine—muscle cancer	0.00817	0.00817	CcSEcCtD
Cefoxitin—Erythema—Dactinomycin—muscle cancer	0.00813	0.00813	CcSEcCtD
Cefoxitin—Vaginal inflammation—Methotrexate—muscle cancer	0.00806	0.00806	CcSEcCtD
Cefoxitin—Pancytopenia—Etoposide—muscle cancer	0.00802	0.00802	CcSEcCtD
Cefoxitin—Neutropenia—Etoposide—muscle cancer	0.00789	0.00789	CcSEcCtD
Cefoxitin—Vaginal infection—Methotrexate—muscle cancer	0.00761	0.00761	CcSEcCtD
Cefoxitin—Aplastic anaemia—Methotrexate—muscle cancer	0.00757	0.00757	CcSEcCtD
Cefoxitin—Anaemia—Dactinomycin—muscle cancer	0.00751	0.00751	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00746	0.00746	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Doxorubicin—muscle cancer	0.00738	0.00738	CcSEcCtD
Cefoxitin—Jaundice—Etoposide—muscle cancer	0.00734	0.00734	CcSEcCtD
Cefoxitin—Leukopenia—Dactinomycin—muscle cancer	0.00727	0.00727	CcSEcCtD
Cefoxitin—Agranulocytosis—Etoposide—muscle cancer	0.00702	0.00702	CcSEcCtD
Cefoxitin—Vaginal inflammation—Doxorubicin—muscle cancer	0.00698	0.00698	CcSEcCtD
Cefoxitin—Thrombophlebitis—Methotrexate—muscle cancer	0.00676	0.00676	CcSEcCtD
Cefoxitin—Anaemia—Vincristine—muscle cancer	0.00671	0.00671	CcSEcCtD
Cefoxitin—Colitis—Doxorubicin—muscle cancer	0.0067	0.0067	CcSEcCtD
Cefoxitin—Urinary tract disorder—Etoposide—muscle cancer	0.00667	0.00667	CcSEcCtD
Cefoxitin—Candida infection—Doxorubicin—muscle cancer	0.00666	0.00666	CcSEcCtD
Cefoxitin—Urethral disorder—Etoposide—muscle cancer	0.00662	0.00662	CcSEcCtD
Cefoxitin—Vaginal infection—Doxorubicin—muscle cancer	0.00659	0.00659	CcSEcCtD
Cefoxitin—Aplastic anaemia—Doxorubicin—muscle cancer	0.00655	0.00655	CcSEcCtD
Cefoxitin—Leukopenia—Vincristine—muscle cancer	0.0065	0.0065	CcSEcCtD
Cefoxitin—Thrombocytopenia—Dactinomycin—muscle cancer	0.00649	0.00649	CcSEcCtD
Cefoxitin—Erythema multiforme—Etoposide—muscle cancer	0.00639	0.00639	CcSEcCtD
Cefoxitin—Rash maculo-papular—Doxorubicin—muscle cancer	0.00634	0.00634	CcSEcCtD
Cefoxitin—Renal failure acute—Methotrexate—muscle cancer	0.00634	0.00634	CcSEcCtD
Cefoxitin—Convulsion—Vincristine—muscle cancer	0.00629	0.00629	CcSEcCtD
Cefoxitin—Flushing—Etoposide—muscle cancer	0.00627	0.00627	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Methotrexate—muscle cancer	0.0062	0.0062	CcSEcCtD
Cefoxitin—Anaphylactic shock—Vincristine—muscle cancer	0.00592	0.00592	CcSEcCtD
Cefoxitin—Phlebitis—Doxorubicin—muscle cancer	0.00588	0.00588	CcSEcCtD
Cefoxitin—Thrombophlebitis—Doxorubicin—muscle cancer	0.00585	0.00585	CcSEcCtD
Cefoxitin—Thrombocytopenia—Vincristine—muscle cancer	0.0058	0.0058	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Doxorubicin—muscle cancer	0.0058	0.0058	CcSEcCtD
Cefoxitin—Pain—Dactinomycin—muscle cancer	0.00567	0.00567	CcSEcCtD
Cefoxitin—Hypotension—Vincristine—muscle cancer	0.00554	0.00554	CcSEcCtD
Cefoxitin—Renal failure acute—Doxorubicin—muscle cancer	0.00549	0.00549	CcSEcCtD
Cefoxitin—Anaemia—Etoposide—muscle cancer	0.00544	0.00544	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00542	0.00542	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00537	0.00537	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00527	0.00527	CcSEcCtD
Cefoxitin—Leukopenia—Etoposide—muscle cancer	0.00526	0.00526	CcSEcCtD
Cefoxitin—Abdominal pain—Dactinomycin—muscle cancer	0.00524	0.00524	CcSEcCtD
Cefoxitin—Body temperature increased—Dactinomycin—muscle cancer	0.00524	0.00524	CcSEcCtD
Cefoxitin—Convulsion—Etoposide—muscle cancer	0.0051	0.0051	CcSEcCtD
Cefoxitin—Pain—Vincristine—muscle cancer	0.00507	0.00507	CcSEcCtD
Cefoxitin—Eosinophilia—Methotrexate—muscle cancer	0.00501	0.00501	CcSEcCtD
Cefoxitin—Hypersensitivity—Dactinomycin—muscle cancer	0.00489	0.00489	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Vincristine—muscle cancer	0.00484	0.00484	CcSEcCtD
Cefoxitin—Pancytopenia—Methotrexate—muscle cancer	0.0048	0.0048	CcSEcCtD
Cefoxitin—Anaphylactic shock—Etoposide—muscle cancer	0.0048	0.0048	CcSEcCtD
Cefoxitin—Neutropenia—Methotrexate—muscle cancer	0.00473	0.00473	CcSEcCtD
Cefoxitin—Thrombocytopenia—Etoposide—muscle cancer	0.0047	0.0047	CcSEcCtD
Cefoxitin—Abdominal pain—Vincristine—muscle cancer	0.00468	0.00468	CcSEcCtD
Cefoxitin—Body temperature increased—Vincristine—muscle cancer	0.00468	0.00468	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00456	0.00456	CcSEcCtD
Cefoxitin—Diarrhoea—Dactinomycin—muscle cancer	0.00454	0.00454	CcSEcCtD
Cefoxitin—Hypotension—Etoposide—muscle cancer	0.00448	0.00448	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00447	0.00447	CcSEcCtD
Cefoxitin—Hypersensitivity—Vincristine—muscle cancer	0.00437	0.00437	CcSEcCtD
Cefoxitin—Eosinophilia—Doxorubicin—muscle cancer	0.00433	0.00433	CcSEcCtD
Cefoxitin—Dyspnoea—Etoposide—muscle cancer	0.00428	0.00428	CcSEcCtD
Cefoxitin—Vomiting—Dactinomycin—muscle cancer	0.00422	0.00422	CcSEcCtD
Cefoxitin—Agranulocytosis—Methotrexate—muscle cancer	0.00421	0.00421	CcSEcCtD
Cefoxitin—Rash—Dactinomycin—muscle cancer	0.00418	0.00418	CcSEcCtD
Cefoxitin—Pancytopenia—Doxorubicin—muscle cancer	0.00416	0.00416	CcSEcCtD
Cefoxitin—Pain—Etoposide—muscle cancer	0.0041	0.0041	CcSEcCtD
Cefoxitin—Neutropenia—Doxorubicin—muscle cancer	0.00409	0.00409	CcSEcCtD
Cefoxitin—Haemoglobin—Methotrexate—muscle cancer	0.00407	0.00407	CcSEcCtD
Cefoxitin—Diarrhoea—Vincristine—muscle cancer	0.00405	0.00405	CcSEcCtD
Cefoxitin—Haemorrhage—Methotrexate—muscle cancer	0.00405	0.00405	CcSEcCtD
Cefoxitin—Urinary tract disorder—Methotrexate—muscle cancer	0.004	0.004	CcSEcCtD
Cefoxitin—Urethral disorder—Methotrexate—muscle cancer	0.00397	0.00397	CcSEcCtD
Cefoxitin—Nausea—Dactinomycin—muscle cancer	0.00394	0.00394	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Etoposide—muscle cancer	0.00392	0.00392	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00387	0.00387	CcSEcCtD
Cefoxitin—Erythema multiforme—Methotrexate—muscle cancer	0.00383	0.00383	CcSEcCtD
Cefoxitin—Urticaria—Etoposide—muscle cancer	0.00381	0.00381	CcSEcCtD
Cefoxitin—Jaundice—Doxorubicin—muscle cancer	0.0038	0.0038	CcSEcCtD
Cefoxitin—Abdominal pain—Etoposide—muscle cancer	0.00379	0.00379	CcSEcCtD
Cefoxitin—Body temperature increased—Etoposide—muscle cancer	0.00379	0.00379	CcSEcCtD
Cefoxitin—Vomiting—Vincristine—muscle cancer	0.00377	0.00377	CcSEcCtD
Cefoxitin—Rash—Vincristine—muscle cancer	0.00374	0.00374	CcSEcCtD
Cefoxitin—Dermatitis—Vincristine—muscle cancer	0.00373	0.00373	CcSEcCtD
Cefoxitin—Agranulocytosis—Doxorubicin—muscle cancer	0.00364	0.00364	CcSEcCtD
Cefoxitin—Hypersensitivity—Etoposide—muscle cancer	0.00354	0.00354	CcSEcCtD
Cefoxitin—Erythema—Methotrexate—muscle cancer	0.00352	0.00352	CcSEcCtD
Cefoxitin—Haemoglobin—Doxorubicin—muscle cancer	0.00352	0.00352	CcSEcCtD
Cefoxitin—Nausea—Vincristine—muscle cancer	0.00352	0.00352	CcSEcCtD
Cefoxitin—Haemorrhage—Doxorubicin—muscle cancer	0.0035	0.0035	CcSEcCtD
Cefoxitin—Urinary tract disorder—Doxorubicin—muscle cancer	0.00346	0.00346	CcSEcCtD
Cefoxitin—Urethral disorder—Doxorubicin—muscle cancer	0.00343	0.00343	CcSEcCtD
Cefoxitin—Pruritus—Etoposide—muscle cancer	0.0034	0.0034	CcSEcCtD
Cefoxitin—Erythema multiforme—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Cefoxitin—Diarrhoea—Etoposide—muscle cancer	0.00328	0.00328	CcSEcCtD
Cefoxitin—Anaemia—Methotrexate—muscle cancer	0.00326	0.00326	CcSEcCtD
Cefoxitin—Flushing—Doxorubicin—muscle cancer	0.00325	0.00325	CcSEcCtD
Cefoxitin—Leukopenia—Methotrexate—muscle cancer	0.00315	0.00315	CcSEcCtD
Cefoxitin—Convulsion—Methotrexate—muscle cancer	0.00305	0.00305	CcSEcCtD
Cefoxitin—Vomiting—Etoposide—muscle cancer	0.00305	0.00305	CcSEcCtD
Cefoxitin—Erythema—Doxorubicin—muscle cancer	0.00305	0.00305	CcSEcCtD
Cefoxitin—Rash—Etoposide—muscle cancer	0.00303	0.00303	CcSEcCtD
Cefoxitin—Dermatitis—Etoposide—muscle cancer	0.00302	0.00302	CcSEcCtD
Cefoxitin—Anaphylactic shock—Methotrexate—muscle cancer	0.00287	0.00287	CcSEcCtD
Cefoxitin—Nausea—Etoposide—muscle cancer	0.00285	0.00285	CcSEcCtD
Cefoxitin—Anaemia—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Cefoxitin—Thrombocytopenia—Methotrexate—muscle cancer	0.00281	0.00281	CcSEcCtD
Cefoxitin—Leukopenia—Doxorubicin—muscle cancer	0.00273	0.00273	CcSEcCtD
Cefoxitin—Hypotension—Methotrexate—muscle cancer	0.00269	0.00269	CcSEcCtD
Cefoxitin—Convulsion—Doxorubicin—muscle cancer	0.00264	0.00264	CcSEcCtD
Cefoxitin—Dyspnoea—Methotrexate—muscle cancer	0.00256	0.00256	CcSEcCtD
Cefoxitin—Anaphylactic shock—Doxorubicin—muscle cancer	0.00249	0.00249	CcSEcCtD
Cefoxitin—Pain—Methotrexate—muscle cancer	0.00246	0.00246	CcSEcCtD
Cefoxitin—Thrombocytopenia—Doxorubicin—muscle cancer	0.00244	0.00244	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Methotrexate—muscle cancer	0.00235	0.00235	CcSEcCtD
Cefoxitin—Hypotension—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Cefoxitin—Urticaria—Methotrexate—muscle cancer	0.00228	0.00228	CcSEcCtD
Cefoxitin—Body temperature increased—Methotrexate—muscle cancer	0.00227	0.00227	CcSEcCtD
Cefoxitin—Abdominal pain—Methotrexate—muscle cancer	0.00227	0.00227	CcSEcCtD
Cefoxitin—Dyspnoea—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Cefoxitin—Pain—Doxorubicin—muscle cancer	0.00213	0.00213	CcSEcCtD
Cefoxitin—Hypersensitivity—Methotrexate—muscle cancer	0.00212	0.00212	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00204	0.00204	CcSEcCtD
Cefoxitin—Pruritus—Methotrexate—muscle cancer	0.00203	0.00203	CcSEcCtD
Cefoxitin—Urticaria—Doxorubicin—muscle cancer	0.00198	0.00198	CcSEcCtD
Cefoxitin—Abdominal pain—Doxorubicin—muscle cancer	0.00197	0.00197	CcSEcCtD
Cefoxitin—Body temperature increased—Doxorubicin—muscle cancer	0.00197	0.00197	CcSEcCtD
Cefoxitin—Diarrhoea—Methotrexate—muscle cancer	0.00197	0.00197	CcSEcCtD
Cefoxitin—Hypersensitivity—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Cefoxitin—Vomiting—Methotrexate—muscle cancer	0.00183	0.00183	CcSEcCtD
Cefoxitin—Rash—Methotrexate—muscle cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Dermatitis—Methotrexate—muscle cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Pruritus—Doxorubicin—muscle cancer	0.00176	0.00176	CcSEcCtD
Cefoxitin—Nausea—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Cefoxitin—Diarrhoea—Doxorubicin—muscle cancer	0.0017	0.0017	CcSEcCtD
Cefoxitin—Vomiting—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Cefoxitin—Rash—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Cefoxitin—Dermatitis—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Cefoxitin—Nausea—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
